The Patent Finder

Methods for Treating Lysosomal Acid Lipase Deficiency in Patients

Alexion Pharmaceuticals, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 5 of these applications claim priority to application 61/403,011, filed Sep 9, 2010. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 10,166,274Methods for Treating Lysosomal Acid Lipase Deficiency in Patients
In force
 · Medium confidence
UsedRemaining
Alexion Pharmaceuticals, Inc.In forceMedium confidence
US 10,407,671Lysosomal Storage Disease Enzymes
In force
 · High confidence
Alexion Pharmaceuticals, Inc.In forceHigh confidence
US 10,858,638Lysosomal Storage Disease Enzymes
In force
 · High confidence
Alexion Pharma LLCIn forceHigh confidence
US 11,560,554Lysosomal Storage Disease Enzymes
In force
 · High confidence
Alexion Pharmaceuticals, Inc.In forceHigh confidence
US 12,076,376Methods for Treating Lysosomal Acid Lipase Deficiency in Patients
In force
 · Low confidence
Alexion Pharmaceuticals, Inc.In forceLow confidence
US 11,400,141Methods for Treating Lysosomal Acid Lipase Deficiency in Patients
In force
 · Low confidence
Alexion Pharmaceuticals, Inc.In forceLow confidence
Application 13/642,790Lysosomal Storage Disease Enzymes
Abandoned
Abandoned Jan 25, 2017
Alexion Pharmaceuticals, Inc.AbandonedAbandoned Jan 25, 2017
Application 14/491,604Lysosomal Storage Disease Enzyme
Abandoned
Abandoned Jul 22, 2016
Alexion Pharmaceuticals, Inc.AbandonedAbandoned Jul 22, 2016
Application 15/177,867Lysosomal Storage Disease Enzymes
Abandoned
Abandoned Oct 6, 2016
Alexion Pharmaceuticals, Inc.AbandonedAbandoned Oct 6, 2016
Application 15/285,025Lysosomal Storage Disease Enzymes
Abandoned
Abandoned Feb 14, 2017
Synageva Biopharma Corp.AbandonedAbandoned Feb 14, 2017
1 more record in this group · Pro
10 of 11 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 11.
Upgrade to Pro
5 of these are in force and held by Alexion Pharmaceuticals, Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited